ImageneBio, Inc. (IMA) dividend history

IMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30

$3.47+0.02 (+0.58%)

Close on Nov 13, 2026Market cap $39.39MP/E –Yield –

Dividends

ImageneBio has not reported a dividend

No dividend per share appears in ImageneBio's annual filings since fiscal 2019.

Where these numbers come from

Parsed from the XBRL in ImageneBio's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-12 reverse split on Jul 28, 2025
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is IMA.

Compare: IMA vs CMPX · IMA vs ARTV · IMA vs SABS · IMA vs PALI · IMA vs INBX

Company	Revenue	Growth
IMA	$800.00K	-77.1%
PALI	$500.00K	–
CMPX	–	–
ARTV	–	–
SABS	–	–
INBX	–	–

Company

Next earnings (est.): Mar 9, 2027, before open
Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
Fiscal year ends: December 31
Employees: 15
Held by institutions: 54.9%
Auditor: PricewaterhouseCoopers LLP
SEC CIK: 1835579

Advertisement
300 × 250

See a number that looks wrong?